Heated tension between state and federal AI regulators is coming, predict two attorneys subspecialized in AI startup success, data privacy and cybersecurity.

A growing chorus of academic physicians, policy experts and public health specialists is harmonizing behind the idea of licensing medical GenAI models like they’re doctors or nurses.

The federal government recently released new data pertaining to the landmark legislation, meant to protect patients from receiving unexpected medical bills. 

If all American voters were single-issue deciders and the cost of healthcare were their issue, Democrat candidates would win the mid-term elections handily. But loyalists of the donkey party shouldn’t be smug around their elephant counterparts. 

The program creates a network of accredited sites where radiation oncologists can complete the final regulatory requirements needed to become authorized users for RPT.

Both recalls are categorized as Class 2, which the FDA designates for issues that have the potential to “cause temporary or medically reversible adverse health consequences."

eMurmer's new Heart AI software was designed to detect both the presence and absence of heart murmurs in digital stethoscope recordings. It can also gather critical hemodynamic data, helping care teams gain a better understanding of the patient's cardiovascular health. 

The Federal Trade Commission said it's seeking a resolution with Cigna, the parent company of the pharmacy benefit manager. The agency filed an antitrust complaint against Express Scripts, Optum Rx and CVS Caremark in 2024, alleging the "Big Three" PBMs use anticompetitive tactics to control the insulin supply chain within their vertical.